Transient potential receptor melastatin-2 (Trpm2) does not influence murine MLL-AF9-driven AML leukemogenesis or in vitro response to chemotherapy. [electronic resource]

By: Contributor(s): Producer: 20170530Description: 596-602.e3 p. digitalISSN:
  • 1873-2399
Subject(s): Online resources: In: Experimental hematology vol. 44
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

There are no comments on this title.

to post a comment.